Product
LY3462817
2 clinical trials
2 indications
Indication
HealthyIndication
Rheumatoid ArthritisClinical trial
A Single-Ascending Dose, Safety, Tolerability, and Pharmacokinetic Study of LY3462817 in Healthy Japanese and Non-Japanese ParticipantsStatus: Completed, Estimated PCD: 2023-03-08
Clinical trial
A Phase 2 Study to Evaluate the Efficacy and Safety of LY3462817 in Participants With Moderately to Severely Active Rheumatoid ArthritisStatus: Completed, Estimated PCD: 2022-01-10